Yasutaka Aoyama

The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen, Yukiko Matsunaga, Kana Hasegawa et al. · Nature Medicine · 2017 · 139 citations

Cancer Immunosurveillance, Immunology, Cellular Immune Response +5

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group

Fumihiko Hayakawa, Toru Sakura, Toshiaki Yujiri et al. · Blood Cancer Journal · 2014 · 104 citations · Full text

Hematological Malignancy, Young Adults, Oncology +13

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

Naoki Hosen, Yoshikazu Matsuoka, Satoshi Kishida et al. · Leukemia · 2012 · 75 citations · Full text

Hematological Malignancy, Immunology, Hematology +6

CD48 as a novel molecular target for antibody therapy in multiple myeloma

Naoki Hosen, Hiroyoshi Ichihara, Atsuko Mugitani et al. · British Journal of Haematology · 2011 · 49 citations · Full text

Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain

Kana Hasegawa, Shunya Ikeda, Moto Yaga et al. · Science Translational Medicine · 2022 · 35 citations · Full text